Visualization of Bone Metastases: Bone Scintigraphy Compared with Octreotide Scintigraphy
| Patient no.* | Bone metastases visible with | Total | ||||
|---|---|---|---|---|---|---|
| BS and OS | BS | OS | ||||
| 1 | 1 | 4 | 1 | 6 | ||
| 2 | 6 | 2 | 8 | |||
| 3 | 7 | 7 | ||||
| 4 | 1 | 1 | ||||
| 6 | 6 | 1 | 8 | 15 | ||
| 8 | 2 | 1 | 3 | |||
| 9 | 3 | 3 | ||||
| 10 | 1 | 1 | ||||
| 11 | 1 | 1 | ||||
| Total | 22 | 10 | 13 | 45 | ||
| % of total (= 45) | 49 | 22 | 29 | 100 | ||
| 95% CI (%) | 34–64 | 10–34 | 16–42 | |||
↵* Patients 5 and 7 did not undergo both procedures.
BS = bone scintigraphy; OS = octreotide scintigraphy.